Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: The filing text identifies the registrant as Zimmer Holdings, Inc., not Zimmer Biomet Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2010
Reporting Period: Quarter ended March 31, 2010
Context: The company reported its quarterly results of operations and financial condition. The detailed earnings release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided Form 8-K text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Non-GAAP Measures Discussed: The filing notes the use of two types of non-GAAP measures in the attached press release:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency effects.
- Adjusted Operating Performance: Adjusted net earnings, adjusted diluted EPS, and adjusted operating profit. These exclude inventory step-up, acquisition, integration, realignment, and other expenses (net of tax).
Material Changes
The filing text does not provide specific data on material changes versus the prior comparable period. It only states that the company reported results for the quarter ended March 31, 2010, and that the press release contains year-over-year percentage increases or decreases on a constant currency basis.
Guidance, Outlook, and Management Commentary
Management Commentary: Management utilizes the non-GAAP measures internally to evaluate business performance. They believe these measures provide investors with:
- More meaningful period-to-period comparisons of ongoing operating results.
- Better identification of operating trends that might be masked by one-time items.
- Enhanced transparency regarding specific expenses.
Guidance: The text mentions that the press release includes "projected adjusted diluted EPS," but the specific guidance figures are not present in this document.
Risks and Contingencies: The filing includes standard disclaimers that non-GAAP measures may not be comparable to other companies and should not substitute for GAAP measures. It also states that the information is furnished, not filed, and the registrant makes no admission as to the materiality of the information.
Investor Verification Checklist
- Review Exhibit 99.1 (the Press Release) for specific revenue, earnings, and cash flow numbers, as they are absent from this 8-K text.
- Verify the reconciliation between the reported non-GAAP measures (adjusted EPS, operating profit) and the most directly comparable GAAP measures.
- Confirm the specific impact of "inventory step-up" and "acquisition, integration, and realignment expenses" on the bottom line.
- Check the "projected adjusted diluted EPS" guidance provided in the press release for future outlook.
- Note the registrant name discrepancy: The filing is for Zimmer Holdings, Inc., whereas the request metadata referenced "Zimmer Biomet Holdings, Inc."